title: Assessment of substance abuse liability in rodents: self-administration, drug discrimination, and locomotor sensitization.
abstract: Assessing abuse liability is a crucial step in the development of a novel chemical entity (NCE) with central nervous system (CNS) activity or with chemical or pharmacological properties in common with known abused substances. Rodent assessment of abuse liability is highly attractive due to its relatively low cost and high predictive validity. Described in this unit are three rodent assays commonly used to provide data on the potential for abuse liability based on the acute effects of NCEs: specifically, self-administration, drug discrimination, and locomotor sensitization. As these assays provide insight into the potential abuse liability of NCEs as well as in vivo pharmacological mechanism(s) of action, they should form a key part of the development process for novel therapeutics aimed at treating CNS disorders.
authors.affiliation: PsychoGenics, Inc., Tarrytown, NY, USA.
authors.forename: Neil E
authors.initials: NE
authors.lastname: Paterson
mesh_terms: D000704:Analysis of Variance; D000822:Animal Husbandry; D000818:Animals; D002406:Catheterization, Peripheral; D002491:Central Nervous System Agents; D003216:Conditioning, Operant; D004192:Discrimination, Psychological; D004867:Equipment Design; D007202:Indicators and Reagents; D007262:Infusions, Intravenous; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D012107:Research Design; D012646:Self Administration; D019966:Substance-Related Disorders / Q000209:etiology*
chemical_list: D002491:Central Nervous System Agents; D007202:Indicators and Reagents